Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00474773 · ClinicalTrials.gov registry record
Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery
A clinical trial, sponsored by St. Louis Joint Replacement Institute.
- Completed
- Registry status
- 107
- Enrollment target
NCT00474773: Completed study, sponsored by St. Louis Joint Replacement Institute.
NCT00474773 is a clinical trial that has completed, run by St. Louis Joint Replacement Institute. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00474773 has completed, sponsored by St. Louis Joint Replacement Institute.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
This study will evaluate the benefits of continuing celecoxib through six weeks of total knee arthroplasty recovery. This is a randomized, double blind study with a group of approximately 130 primary total knee patients. All patients will receive celecoxib throughout their hospitalization as per current minimally invasive total knee arthroplasty protocol. At the time of hospital discharge, participating patients will be randomly placed on either celecoxib 200mg twice a day or a placebo twice a day. This study will determine if the continued use of celecoxib for six weeks after total knee arthroplasty hospitalization will further decrease narcotic consumption, improve knee range of motion, improve ambulatory ability, and improve patient satisfaction over patients receiving celecoxib only during the acute hospitalization.
Interventions
- DRUG Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00474773
The ClinicalTrials.gov registry entry for NCT00474773 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis Joint Replacement Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Celecoxib is the first listed.
NCT00474773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00474773 about?
NCT00474773 is a clinical study titled "Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery". This study will evaluate the benefits of continuing celecoxib through six weeks of total knee arthroplasty recovery. This is a randomized, double blind study with a group of approximately 130 primary total knee patients. All patients will receive celecoxib throughout their hospitalization as per cur...
What is the current status of trial NCT00474773?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2007-06. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00474773?
The interventions under investigation include: Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00474773?
This trial is sponsored by St. Louis Joint Replacement Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.